Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 19 November 2024
Kuros Biosciences Expands into Extremities Markets
Press Release, 10 October 2024
Adhoc Press Release
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024
Press Release, 8 August 2024
Adhoc Press Release
Kuros Biosciences Reports First Half of 2024 Results
Press Release, 25 June 2024
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Press Release, 24 April 2024
Adhoc Press Release
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOs sales
Press Release, 17 April 2024
Annual General Meeting of Kuros Biosciences approves all resolutions
press-releases